Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Tear evaporation from the ocular surface" refers to the **physical process by which water in the tear film is lost as vapor** from the exposed eye between blinks. This process is regulated by several components of the tear film—primarily its outermost lipid layer, which acts as a barrier to slow down water loss. When this lipid layer is deficient or disrupted, excessive tear evaporation occurs, leading to increased osmolarity and desiccation stress on epithelial cells. This can result in symptoms and signs characteristic of **evaporative dry eye disease**, including irritation, inflammation, tissue damage, and chronic discomfort. The most common underlying cause for excessive tear evaporation is **meibomian gland dysfunction**—a condition where glands in the eyelids fail to secrete enough oil into the tears. Additional contributing factors include lifestyle elements that reduce blink rate (such as prolonged screen use), environmental conditions with low humidity or high airflow, contact lens wear, hormonal changes affecting gland function, and certain medications. While "tear evaporation from ocular surface" describes an important pathophysiological mechanism central to dry eye disease—especially its evaporative subtype—it does not represent a discrete molecular target such as an enzyme or receptor. Instead, it reflects an outcome influenced by multiple biological structures and processes; thus it should not be classified as a therapeutic target itself but rather as a clinical phenomenon resulting from dysfunctions elsewhere in ocular physiology.[1][3][4][5][6] In summary: "Tear evaporation from ocular surface" is best understood as *a physiological process* relevant for disease mechanisms but not itself a druggable molecular entity or canonical therapeutic target.
Supplementation of the lipid layer to reduce evaporation; Lubrication and stabilization of the tear film
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tear evaporation from ocular surface.